Mylan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 125.00 Cr
- Paid Up Capital ₹ 48.70 Cr
- Company Age 40 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5,501.38 Cr
- Revenue Growth -8.72%
- Profit Growth -25.28%
- Ebitda -5.28%
- Net Worth 4.07%
- Total Assets 0.52%
About Mylan Laboratories
Mylan Laboratories Limited (MLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 29 November 1984 and has a history of 40 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Herren Drugs & Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 125.00 Cr and a paid-up capital of Rs 48.70 Cr.
The company has closed loans amounting to ₹5,501.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mylan Laboratories Limited India are Sarada Bhagawati as CFO and Nagaraj Bodige as Company Secretary. Rajiv Malik, Sarada Bhagawati, Akshay Nanda, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231TG1984PLC005146
- Company No.
005146
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Nov 1984
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
What products or services does Mylan Laboratories Limited offer?
Mylan Laboratories Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Tenofovir Tablet, Anti Infective Agent, Pain Relief Spray, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Antibiotic Injection.
Mylan Laboratories Limited
Explore comprehensive data for Mylan Laboratories Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Mylan Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarada Bhagawati  | CFO | 01-Nov-2014 | Current |
| Nagaraj Bodige | Company Secretary | 25-Jul-2011 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Malik | Director | 28-Jul-2005 | Current |
| Sarada Bhagawati | Whole-Time Director and Cfo | 01-Nov-2014 | Current |
| Akshay Nanda | Director | 11-Mar-2024 | Current |
| Arvind Kanda | Whole-Time Director | 02-Apr-2024 | Current |
| Ramya Suresh | Director | 14-May-2024 | Current |
Financial Performance of Mylan Laboratories.
Mylan Laboratories Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.72% decrease. The company also saw a substantial fall in profitability, with a 25.28% decrease in profit. The company's net worth moved up by a moderate rise of 4.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mylan Laboratories?
In 2023, Mylan Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biocon Biologics LimitedRajiv Malik is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹5,501.38 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 1826.18 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 897.03 Cr
- Axis Bank Limited : 845.05 Cr
- Central Bank Of India : 367.50 Cr
- Yes Bank Limited : 190.00 Cr
- Others : 1375.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2013 | Icici Bank Limited | ₹170.00 Cr | Satisfied |
| 27 Nov 2012 | Yes Bank Limited | ₹40.00 Cr | Satisfied |
| 08 Oct 2012 | Export - Import Bank Of India | ₹150.00 Cr | Satisfied |
| 18 Jul 2012 | The Ratnakar Bank Limited | ₹50.00 Cr | Satisfied |
| 10 Jul 2012 | Yes Bank Limited | ₹60.00 Cr | Satisfied |
How Many Employees Work at Mylan Laboratories?
Mylan Laboratories has a workforce of 11193 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mylan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mylan Laboratories
Recent activity within the organization
- Director Appointment
Ramya Suresh was appointed as a Director was appointed as a Director on 14 May 2024 & has been associated with this company since 1 year 1 day .
- Director Appointment
Arvind Shankar Kanda was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 02 Apr 2024 & has been associated with this company since 1 year 1 month .
- Director Appointment
Akshay Nanda was appointed as a Director was appointed as a Director on 11 Mar 2024 & has been associated with this company since 1 year 2 months .
- Annual General Meeting
Mylan Laboratories Limited last Annual general meeting of members was held on 31 Jul 2023 as per latest MCA records.
- Balance Sheet
Mylan Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Charges
A charge registered on 12 Apr 2005 via Charge ID 90128817 with Andhra Bank was fully satisfied on 11 Dec 2014.
Recent News, Updates & Announcement
India's Biocon raises $129mln from Kotak to fund biosimilars deal.Biocon Biologics completed the $3.34-billion acquisition of U.S.-based Viatris's biosimilars business in late November .
- Biocon, Mylan launch insulin biosimilar in Australia.
Insulin glargine is indicated for the treatment of type 1 diabetes mellitus in adults, adolescents and children aged six years and above and type 2 diabetes mellitus in adults. .
- Biocon's Partner Mylan Faces Setback with USFDA Letter and Observations on Insulin Drug Application.
When Biocon's partner Mylan filed for a new insulin drug, the USFDA issued a letter and four observations after inspecting one of Biocon's facilities. The letter stated that the application will not be approved in its current form. Biocon is working to fix the issues and is confident in the quality of their application. The facility also received four observations, but Biocon is confident they can address them..
Frequently asked questions
What is the Incorporation or founding date of Mylan Laboratories Limited?
Mylan Laboratories Limited was incorporated on 29 Nov 1984.
What is authorized share capital and paid-up capital of Mylan Laboratories Limited?
The authorized share capital of Mylan Laboratories Limited is ₹ 125.00 Cr and paid-up capital is ₹ 48.70 Cr.
Who are the current board members & directors of Mylan Laboratories Limited?
Currently 7 directors are associated with Mylan Laboratories Limited.
- Rajiv Malik
- Sarada Kalyani Bhagawati
- Akshay Nanda
- Arvind Shankar Kanda
- Ramya Suresh
- Sarada Kalyani Bhagawati
- Nagaraj Goud Bodige
What is the registered address of Mylan Laboratories Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mylan Laboratories Limited is Plot No.564/A/22 Road No.92 Jubilee Hills India, Hyderabad, Telangana, 500096.
What is the corporate identification number (CIN) and company number of Mylan Laboratories Limited?
The corporate identification number (CIN) of Mylan Laboratories Limited is U24231TG1984PLC005146 and the company number is 005146 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mylan Laboratories Limited?
The Official website of Mylan Laboratories Limited is https://www.viatris.com
What has been the recent revenue trend for Mylan Laboratories Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Mylan Laboratories Limited has fallen by -8.72%.
How many employees does Mylan Laboratories Limited currently have?
As Per 2023 financial reports, 11193 employees are currently employed by Mylan Laboratories Limited.
What change has been observed in the net worth of Mylan Laboratories Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Mylan Laboratories Limited has experienced an upsurge of 4.07%.
When was the last Balance Sheet of Mylan Laboratories Limited filed with the ROC?
The most recent Balance Sheet for Mylan Laboratories Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Rajiv LuthraDirector
Mohit SarafDirector
Jagdish DoreManaging Director
Chunduri RamakrishnaDirector
Arun DuggalDirectorKS
Kugalur SubrahmanianDirectorPN
Prasad NimmagaddaDirectorSS
Seshan SrinivasanDirector
Similar Companies Based on Drug Formulation & Development
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India
Intas Pharmaceuticals Limited Ahmedabad, Gujarat, India